Senior insider sale
Chief Operating Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$662.5K
51.27K shares
What this filing means
DOWDEN NATHAN J plans to sell 51.27K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $662.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001950047-26-004004
Officer· Chief Operating Officer
Since Oct 2021
51.27K
Shares to sell
$662.5K
Approx. market value
15K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/4/2026
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Exercise of Stock Options Cash | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
11.89K
Market value
$155.2K
3/10/2026
—Completed
Units to sell
3.12K
Market value
$40.6K
3/9/2026
—Completed
Units to sell
14.04K
Market value
$165.0K
3/3/2026
—Completed
Units to sell
7.22K
Market value
$84.2K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$217.5K
5/4/2026
Total
Units
51.27K
Value
$662.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 11.89K | $155.2K | — | Completed |
3/9/2026 | 3.12K | $40.6K | — | Completed |
3/3/2026 | 14.04K | $165.0K | — | Completed |
3/2/2026 | 7.22K | $84.2K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 15K | $217.5K | NASDAQ | Planned |
| Total | 51.27K | $662.5K | ||